Unknown

Dataset Information

0

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.


ABSTRACT: Adoptive transfer of large numbers of tumor-reactive CD8(+) cytotoxic T lymphocytes (CTLs) expanded and differentiated in vitro has shown promising clinical activity against cancer. However, such protocols are complicated by extensive ex vivo manipulations of tumor-reactive cells and have largely focused on CD8(+) CTLs, with much less emphasis on the role and contribution of CD4(+) T cells. Using a mouse model of advanced melanoma, we found that transfer of small numbers of naive tumor-reactive CD4(+) T cells into lymphopenic recipients induces substantial T cell expansion, differentiation, and regression of large established tumors without the need for in vitro manipulation. Surprisingly, CD4(+) T cells developed cytotoxic activity, and tumor rejection was dependent on class II-restricted recognition of tumors by tumor-reactive CD4(+) T cells. Furthermore, blockade of the coinhibitory receptor CTL-associated antigen 4 (CTLA-4) on the transferred CD4(+) T cells resulted in greater expansion of effector T cells, diminished accumulation of tumor-reactive regulatory T cells, and superior antitumor activity capable of inducing regression of spontaneous mouse melanoma. These findings suggest a novel potential therapeutic role for cytotoxic CD4(+) T cells and CTLA-4 blockade in cancer immunotherapy, and demonstrate the potential advantages of differentiating tumor-reactive CD4(+) cells in vivo over current protocols favoring in vitro expansion and differentiation.

SUBMITTER: Quezada SA 

PROVIDER: S-EPMC2839156 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Quezada Sergio A SA   Simpson Tyler R TR   Peggs Karl S KS   Merghoub Taha T   Vider Jelena J   Fan Xiaozhou X   Blasberg Ronald R   Yagita Hideo H   Muranski Pawel P   Antony Paul A PA   Restifo Nicholas P NP   Allison James P JP  

The Journal of experimental medicine 20100215 3


Adoptive transfer of large numbers of tumor-reactive CD8(+) cytotoxic T lymphocytes (CTLs) expanded and differentiated in vitro has shown promising clinical activity against cancer. However, such protocols are complicated by extensive ex vivo manipulations of tumor-reactive cells and have largely focused on CD8(+) CTLs, with much less emphasis on the role and contribution of CD4(+) T cells. Using a mouse model of advanced melanoma, we found that transfer of small numbers of naive tumor-reactive  ...[more]

Similar Datasets

2010-01-14 | E-GEOD-19904 | biostudies-arrayexpress
2010-01-15 | GSE19904 | GEO
| S-EPMC2839147 | biostudies-literature
| S-EPMC2442746 | biostudies-literature
2010-05-25 | E-GEOD-10814 | biostudies-arrayexpress
2008-03-15 | GSE10814 | GEO
| S-EPMC2935308 | biostudies-literature
| S-EPMC9243303 | biostudies-literature
| S-EPMC3720758 | biostudies-literature
| S-EPMC3880021 | biostudies-literature